Brief: Windtree Therapeutics Announces Closing Of $12.42 Million Underwritten Public Offering Including Full Exercise Of Overallotment Option
24/04/2023 22:00
April 24 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS ANNOUNCES CLOSING OF $12.42 MILLION
UNDERWRITTEN PUBLIC OFFERING INCLUDING FULL EXERCISE OF
OVERALLOTMENT OPTION
Source text for Eikon: ID:nGNXbdZnx0
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study